Therapeutic Goods Administration

Rediff.com » News » Therapeutic Goods Administration

News for Therapeutic Goods Administration

News
Business

Nigeria flags 2 India-made drugs as substandard, having toxins

Oral paracetamol and another cough medicine manufactured by companies based in Mumbai and Punjab were found to be “sub-standard or found to be containing toxins”, reports Sohini Das.......

WHO issues alert against syrup by Indian manufacturer

The World Health Organisation on Tuesday issued a product alert over contaminated syrup by an Indian manufacturer, warning that it is unsafe for use, especially in children, and may result in......

Australia to ease travel restrictions from December 1

Australia on Monday announced easing of its stringent pandemic-related travel restrictions from next month, a decision that is expected to help thousands of Indian students return to that country.......

Australia formally recognises India's Covaxin

Australia's medicines and medical devices regulator on Monday formally recognised India's Covaxin, a vaccine against the coronavirus as the country's border was reopened for the first time in......

Biological E plans to make 1.5 billion Corbevax jabs in 2021

By 2022, there is a plan to make an mRNA-technology vaccine, for which it has tied up with Canadian firm Providence Therapeutics.The vaccine, named PTX-COVID19-B, is under development in Canada and......

Indian pharma cos get a shot in the arm in $12-bn Australian drug market

Indian drug firms get a shot in the arm in the $12 bn Australian drug market as the Therapeutic Goods Administration (TGA), Australia agrees to accelerate the drug approval process in that country......

Quality perceptions hobble Jan Aushadi drugs

Large pharmaceutical firms feel that if the quality parameters and assurance levels are brought up to the level of branded generics, then Jan Aushadhi medicines would find it difficult to retain......

2017 begins with a bang for outbound M&A deals

Indian companies have made acquisitions of $1 billion so far in January Outbound acquisitions by Indian companies have seen a surge in the first month of 2017 after a lull for the past three......

Dilip Shanghvi's X factor shows up in different ways

If you look at Mr Shanghvi and his business, you may find several things wrong. Unlike industry doyens Parvinder Singh of Ranbaxy, Anji Reddy of Dr Reddy’s Laboratories and Yusuf Hamied......

Sun Pharma draws up plan to fix ailing Ranbaxy

The coming together of India's two very large drug makers, Sun Pharmaceutical Industries and Ranbaxy Laboratories, has created a stir in the pharmaceutical world. Sun's $3.2-billion all-share......

Rediff News

Therapeutic Goods Administration

News for Therapeutic Goods Administration

Nigeria flags 2 India-made drugs as substandard, having toxins

WHO issues alert against syrup by Indian manufacturer

Australia to ease travel restrictions from December 1

Australia formally recognises India's Covaxin

Biological E plans to make 1.5 billion Corbevax jabs in 2021

Indian pharma cos get a shot in the arm in $12-bn Australian drug market

Quality perceptions hobble Jan Aushadi drugs

2017 begins with a bang for outbound M&A deals

Dilip Shanghvi's X factor shows up in different ways

Sun Pharma draws up plan to fix ailing Ranbaxy

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS